Nektar Therapeutics sues Lilly for breach of contract around skin drug

From the start of its lawsuit, filed Monday in U.S. District Court in Northern California, Nektar lets loose: “This case involves the all-too-familiar story of a large pharmaceutical company elevating profits over all else.”
Click here to view original post